Coronary Artery Disease Clinical Trial
— SATURATIONOfficial title:
Southeastern Europe Microcirculation Registry
NCT number | NCT06393478 |
Other study ID # | IKVBD-KARD-001 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | March 1, 2024 |
Est. completion date | March 1, 2034 |
SATURATION is a prospective multicenter registry of consecutive patients who undergo coronary physiology testing using Pressure Wire X and Coroflow Coroventis Cardiovascular System software (Abbott Vascular, Abbott Park, IL, USA) and to assess the regional practice of patient selection, cardiovascular outcomes and additional procedures (stress testing, angiography, etc.) done after comprehensive invasive coronary physiology evaluation.
Status | Recruiting |
Enrollment | 900 |
Est. completion date | March 1, 2034 |
Est. primary completion date | March 1, 2029 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adults of both sexes older than 18 years - Angina symptoms or angina equivalent - Referred to Cath lab for evaluation of CAD - Invasive physiology testing performed (microcirculation testing +/- vasospasm testing) using Coroflow Coroventis Cardiovascular system (Abbott Vascular, Abbott Park, IL, USA) Exclusion Criteria: - Persons under the age of 18 - Pregnant of nursing - No coronary physiology measurements performed |
Country | Name | City | State |
---|---|---|---|
Croatia | CHC Rijeka | Rijeka | |
Croatia | KBC Zagreb | Zagreb | |
Greece | Hippokration Hospital | Athens | |
Greece | MITERA General Hospital | Athens | |
Greece | Heraklion University Hospital | Heraklion | |
Greece | University Hospital of Patras | Patras | |
Israel | Tel Aviv Sourasky MC | Tel Aviv | |
Serbia | Institute for cardiovascular diseases Dedinje | Belgrade | |
Serbia | Institute for cardiovascular diseases Vojvodine | Novi Sad | |
Slovenia | UMC Ljubljana | Ljubljana |
Lead Sponsor | Collaborator |
---|---|
Institute for Cardiovascular Diseases "Dedinje" | Abbott Medical Devices |
Croatia, Greece, Israel, Serbia, Slovenia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | all-cause death and non-fatal MI | The study will record aggregate number of participants that died and/or suffered from myocardial infarction after invasive physiology procedure | 5 years | |
Primary | composite MACE | The study will record aggregate number of participants that died from any cause and/or experienced non-fatal myocardial infarction and/or coronary angioplasty procedure and/or hospitalization for cardiovascular causes (acute coronary syndrome, heart failure, angina, repeated coronary angiography) | 5 years | |
Secondary | all-cause death | The study will record number of participants that died after invasive coronary physiology | 5 years | |
Secondary | cardiovascular death | The study will record number of participants that died due to cardiovascular causes after invasive coronary physiology | 5 years | |
Secondary | myocardial infarction | The study will record the number of participants that suffered from myocardial infarction after invasive coronary physiology | 5 years | |
Secondary | coronary revascularization | The study will record number of participants that undergo surgical and/or percutaneous revascularization after invasive coronary physiology | 5 years | |
Secondary | stroke | The study will record the number of participants that suffered from stroke after invasive coronary physiology | 5 years | |
Secondary | hospitalization for heart failure | The study will record the number of participants that are hospitalized for heart failure after invasive coronary physiology | 5 years | |
Secondary | hospitalization for acute coronary syndrome | The study will record the number of participants that are hospitalized for acute coronary syndrome after invasive coronary physiology | 5 years | |
Secondary | repeated coronary angiography | The study will record the number of participants that undergo repeated coronary angiography after invasive coronary physiology | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |